CU6 clarity pharmaceuticals ltd

Ann: First patient treated in the Phase II of the SECuRE trial, page-3

  1. 8,193 Posts.
    lightbulb Created with Sketch. 2047
    As part of this trial and subsequent p3 will that confer the IP rights to Clarity on cu67 as a single agent and a combo therapy if approved?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$2.21
Change
0.045(2.08%)
Mkt cap ! $705.3M
Open High Low Value Volume
$2.15 $2.29 $2.13 $2.799M 1.268M

Buyers (Bids)

No. Vol. Price($)
20 19746 $2.20
 

Sellers (Offers)

Price($) Vol. No.
$2.21 9597 22
View Market Depth
Last trade - 13.49pm 16/06/2025 (20 minute delay) ?
CU6 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.